PONM

PONM is a biotechnology company specializing in the development and commercialization of rapid, point-of-care molecular diagnostic solutions. The company's core technology focuses on high-sensitivity PCR-based testing that can be performed outside of traditional laboratory settings, providing results in minutes rather than days. PONM's product suite is designed to address critical needs in infectious disease management, including respiratory and sexually transmitted infections. By decentralizing molecular testing, the company aims to improve patient outcomes through immediate diagnosis and targeted treatment initiation. PONM serves a variety of healthcare settings, from clinics and pharmacies to emergency departments and resource-limited environments.